Report Scope:
The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market. The report segments the market for IVD analyzers based on analyzer type, level of automation, design, therapeutic area, and end user. The market is segmented into immunoassay analyzers, clinical chemistry, hematology and coagulation, molecular diagnostics, PoC analyzers and others based on test type. Based on level of automation, analyzers are categorized into semi-automated and fully automated. Based on therapeutic area, the market is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. The market is segmented into diagnostic centers, hospitals and clinics, research institutions and others based on end user. The report includes profiles of the leading companies with information about their business segments, financials, product portfolios, and recent developments.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). The North America region includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., France, and the rest of Europe. The Asia-Pacific region includes China, India, Japan, and the rest of Asia-Pacific.

Report Includes:

  • 39 data tables and 34 additional tables
  • An analysis of the global market for in vitro diagnostics (IVD) analyzers
  • Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
  • Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19’s impact on the IVD industry
  • Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies’ ESG scores, future of ESG, case studies and the ESG practices of leading companies
  • Overview of the emerging new technologies and patents in the market
  • Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
  • Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific